1 Stimulation of the vanilloid receptor-1 (TRPV1) results in the activation of nociceptive and neurogenic in¯ammatory responses. Poor speci®city and potency of TRPV1 antagonists has, however, limited the clari®cation of the physiological role of TRPV1.
Introduction
A subset of primary sensory neurons found within dorsal root (DRG), trigeminal and vagal ganglia, which include both C and Ad ®bres, contain the neuropeptides, substance P (SP), neurokinin A (NKA) and calcitonin gene-related peptide (CGRP) (Holzer, 1991) . These neuropeptides are released from central and peripheral terminals of these neurons upon activation of a recently cloned (Caterina et al., 1997) , non-selective cation channel that belongs to the transient receptor potential (TRP) family of channels (Gunthorpe et al., 2002) . Because of the ability of this channel to be gated by capsaicin, the pungent ingredient found in chilli peppers, and by other molecules with a vanilloid moiety (Szallasi & Blumberg, 1999) it has been termed vanilloid receptor-1 (TRPV1) (Caterina et al., 1997) . An heterogeneous series of physical and chemical agents has been shown to activate and/or potentiate the activity of TRPV1. These agents include noxious heat (43 ± 528C) (Caterina et al., 1997) , protons (pH 6-5) (Bevan & Geppetti, 1994; Tominaga et al., 1998) , anandamide (Zygmunt et al., 1999) , 12-HPETE and other lipid derivatives (Hwang et al., 2000) and ethanol (Trevisani et al., 2002) . Two dierent studies performed in TRPV1 null mice indicate that TRPV1 mediates thermal hyperalgesia (Caterina et al., 2000; Davis et al., 2000) . Recent ®ndings that TRPV1 immunoreactivity is higher in gastrointestinal tissues taken from patients with ulcerative colitis and Crohn's disease (Yiangou et al., 2001) , suggest that TRPV1 may play a role in the mechanism of these in¯ammatory conditions. However, the role of TRPV1 in the pathophysiology of such diseases is still elusive, and one of the reasons for these uncertainties is the absence of high anity and selective TRPV1 antagonists.
Ruthenium red, a dye that exhibits properties of noncompetitive antagonism for the TRPV1 (Amann & Maggi, 1997; Liu & Simon, 1997; Szallasi et al., 1993; Wardle et al., 1996) . In addition, at the concentrations (*10 mM) often required for antagonistic activity, capsazepine has shown non-speci®c eects, including blockage of voltage-gated calcium channels (Docherty et al., 1997) and nicotinic receptors (Liu & Simon, 1997; Wardle et al., 1997) .
The ultrapotent TRPV1 agonist, resiniferatoxin (RTX), a toxin isolated from the cactus Euphorbia resinifera (Szallasi & Blumberg, 1999) has been successfully used to label the TRPV1 in radioreceptor binding assays by using its [ 3 H] and [ 125 I] derivatives. Recently, it has been reported (Wahl et al., 2001) that the iodinated form of resiniferatoxin (iodoresiniferatoxin (I-RTX): 6,7-Deepoxy-6,7-didehydro-5-deoxy-21-dephenyl-21-(phenylmethyl)-daphnetoxin,20-(4-hydroxy-5iodo-3-methoxybenzeneacetate) inhibited the binding of [ 125 I]-RTX to rat spinal cord membranes and HEK293 cells transfected with the rat TRPV1 with an anity much higher than capsazepine (K i , *5 nM and *5 mM, respectively). Because I-RTX did not show any agonistic activity, blocked capsaicin-induced currents in Xenopus leavis oocytes expressing the rat TRPV1 (IC 50 3.9 nM) and reduced the nociceptive response induced by intrathecal capsaicin injection in mice, it was proposed that I-RTX behaves as a high anity TRPV1 antagonist (Wahl et al., 2001) .
A high anity and selective TRPV1 antagonist, in addition to being a lead for developing novel analgesics, may be of unprecedented value for discovering endogenous TRPV1 agonists and exploring the physiological role of TRPV1. TRPV1 stimulation results in the activation of a series of nociceptive and neurogenic in¯ammatory responses (Holzer, 1991; Szallasi & Blumberg, 1999; Szallasi & Di Marzo, 2000) . Thus, the present study was undertaken to de®ne the ability of I-RTX to inhibit`typical' TRPV1 mediated responses in dierent mammalian species. These responses include capsaicin-induced increases in intracellular Ca 2+ ([Ca 2+ ] i ) in cultured primary sensory neurones or HEK293 cells transfected with the human TRPV1 (hTRPV1 HEK293), release of CGRP and SP from slices of rat dorsal spinal cord, contraction of isolated guinea-pig bronchus or urinary bladder and of rat urinary bladder, neurogenic plasma protein extravasation in the mouse urinary bladder and acetic acid-induced writhing response in mice.
Methods

Animals and tissues
Male albino Dunkin-Hartley guinea-pigs (* 250 g), Sprague-Dawley rats (*300 g) and Swiss mice (*30 g) were used (Morini, Italy). All experiments complied with the national guidelines and were approved by the regional ethics committee.
Ca 2+ fluorescence measurements in cultured rat trigeminal ganglia and hTRPV1 HEK293 cells Newborn rats (2 ± 3 days old) were terminally anaesthetized and decapitated. The trigeminal ganglia were removed and rapidly placed in cold phosphate buered solution (PBS) before being transferred to collagenase/dispase (1 mg ml 71 dissolved in Ca 2+ -Mg 2+ -free PBS) for 35 min at 378C. Enrichment of the fraction of nociceptive neurons was obtained following the methods reported previously (Gilabert & McNaughton, 1997) . After the enzymatic treatment ganglia were rinsed three times with Ca 2+ -Mg 2+ -free PBS and then placed in 2 ml of cold DMEM supplemented with 10% foetal bovine serum (FBS, heat inactivated), 2 mM L-glutamine, 100 u ml 71 penicillin and 100 mg ml 71 streptomycin. The ganglia were then dissociated into single cells by several passages through a series of syringe needles (23G down to 25G). Finally, the complex of medium and ganglia cells were sieved through a 40 mm ®lter to remove debris and topped up with 8 ml of DMEM medium and centrifuged (2006g for 5 min). The ®nal cell pellet was re-suspended in DMEM medium (supplemented with 100 ng ml 71 mouse Nerve Growth Factor (mouse-NGF-7S) and cytosine-b-D-arabinofuranoside free base (ARA-C) 2.5 mM). Cells were plated on poly-L-lysine (8.3 mM) and laminin (5 mM) coated 25 mm glass cover slips and kept for 2 to 5 days at 378C in a humidi®ed incubator gassed with 5% CO 2 and air. Cells were fed on the second day (and subsequent alternate days) with DMEM medium (with 1% FBS instead of 10% FBS). In another set of experiments hTRPV1 HEK293 were also used.
Experiments were performed as previously reported in rat DRG neurons (Tognetto et al., 2001) . Brie¯y, plated neurons and hTRPV1 HEK293 cells (2 to 5 days) were loaded with Fura-2-AM-ester (3 mM) in Ca 2+ buer solution of the following composition (mM): CaCl 2 1.4, KCl 5.4, MgSO 4 0.4, NaCl 135, D-glucose 5, HEPES 10 with BSA 0.1%, at pH 7.4, for 40 min at 378C, washed twice with the Ca 2+ buer solution and transferred to a chamber on the stage of Nikon eclipse TE300 microscope. The dye was excited at 340 and 380 nm to indicate relative [Ca 2+ ] i changes by the F 340 / F 380 ratio recorded with a dynamic image analysis system (Laboratory Automation 2.0, RCS, Florence, Italy). Capsaicin (0.1 mM), I-RTX (0.001 ± 1 nM), capsazepine (0.01 ± 10 mM) or their respective vehicles were added to the chamber. A calibration curve using a buer containing Fura-2-AM-ester and determinant concentrations of free Ca 2+ (Kudo et al., 1986 ) was used to convert the data obtained from F 340 /F 380 ratio to [Ca 2+ ] i (nM). Furthermore, I-RTX (10 nM) did not aect the response produced by ionomycin (5 mM) (data not shown).
CGRP-LI and SP-LI release from rat spinal cord
Rats were terminally anaesthetized and decapitated. The dorsal spinal cord was prepared at 48C using a tissue slicer (McIlwain Tissue Chopper, U.K.). Slices (*100 mg) were placed in 2 ml chambers and superfused at 0.4 ml ml 71 with a Krebs solution of the following composition (mM) NaCl 119, NaHCO 3 25, KH 2 PO 4 1.2, MgSO 4 1.5, CaCl 2 2.5, KCl 4.7 and D-glucose 11. To the basic Krebs solution the following agents were added: 0.1% bovine serum albumin (BSA), 1 mM phosphoramidon and 1 mM captopril, and maintained at 378C (gassed with 95% O 2 and 5% CO 2 ). High KCl solution was prepared by changing isoosmotically NaCl with KCl. After a 90 min stabilization period, 10 min fractions were collected into acetic acid (®nal solution 2 N). Two pre-stimuli samples were taken at 10 min intervals followed by a third set of samples during stimulation. A ®nal post-stimulus 10 min sample was also collected. At the end of the experiment tissues were blotted and weighed. Fractions were freeze-dried, re-constituted with assay buer, and analysed by enzyme-immunoassays for CGRP and SP like immunoreactivities (LI) (CGRP-LI and SP-LI, respectively) according to the methods reported previously (Frobert et al., 1999; Ricciardolo et al., 2000) . The detection limits of the assays were 5 pg ml 71 for CGRP and 2 pg ml 71 for SP. The level of release of CGRP-LI and SP-LI were calculated by subtracting the mean pre-stimulus value from those values obtained during-and post-stimulation. The results are expressed as fmol of peptide g 71 tissue 20 min. The highest concentration of capsaicin (10 mM), I-RTX (1 nM) and capsazepine (10 mM) did not show any signi®cant crossreactivity with CGRP and SP antisera.
Isolated tissues in organ baths
Animals were sacri®ced by cervical dislocation and the airways and urinary bladder of the guinea-pig, and urinary bladder of the rat were removed. In the guinea-pig, rings from main bronchi (approximately 2 mm in width) were suspended with a resting tension of 1.5 g. In both the guineapig and rat urinary bladders vertical halves were suspended with a resting tension of 1 g. The tissues were bathed and aerated (95% O 2 and 5% CO 2 ) with Krebs solution (described above) which was maintained at 378C, and contained phosphoramidon (1 mM) and captopril (1 mM) to minimize peptide degradation. Tissues were allowed to equilibrate for 60 min prior to the beginning and between each set of experiments (washed every 5 min). In all experiments the tissues were ®rst contracted with carbachol (CCh, 1 mM).
Cumulative concentration-response curves were performed with capsaicin (0.1 nM ± 100 mM) and SP (0.1 nM ± 1 mM) either in the presence of the TRPV1 antagonists, I-RTX (0.01 ± 1 mM in bronchi and 0.1 ± 10 nM in urinary bladders) and capsazepine (0.1 ± 10 mM in all tissues) or their respective vehicles. In a subset of experiments cumulative concentrationresponse curves were also performed with resiniferatoxin (0.1 nM ± 1 mM).
Plasma extravasation
Swiss mice were anaesthetized with xylazine (100 mg kg 71 , i.m.) and ketamine (50 mg kg 71 , i.m.). Evans Blue (30 mg kg 71 ) was injected into the femoral vein and 1 min later the administration of capsaicin (1 mmol kg 71 , i.v.) was performed. After ®ve additional min animals were transcardially perfused. Pre-treatments with I-RTX (0.1 ± 0.5 mmol kg 71 , i.v.), capsazepine (0.5 ± 10 mmol kg 71 , i.v.), or their respective vehicles were given 20 and 15 min prior to the injection of the dye, respectively. Urinary bladders were removed, weighed and incubated in 1 ml of formamide for 24 h in the dark, at room temperature. The amount of extravasated Evans Blue was measured spectrophotometrically at 620 nm.
Writhing test
Swiss mice (*25 g) were intraperitoneally (i.p.) injected with acetic acid (0.9%, 5 ml kg 71 ) after pretreatment with I-RTX (0.1 ± 1 mmol kg 71 , i.p. 20 min prior to the stimulus), capsazepine (1 ± 10 mmol kg 71 , i.p. 60 min prior to the stimulus) or their vehicles (0.01 ± 0.1% DMSO and 0.01 ± 0.1% ethanol, respectively).
Materials
Drugs and reagents were obtained from the indicated companies: acetic acid, capsaicin, capsazepine, captopril, ionomycin, laminin, phosphoramidon, poly-L-lysine, resiniferatoxin, substance P (Sigma, Italy); iodo-resiniferatoxin (Tocris, U.K.); mouse NGF-7S and collagenase/dispase (Roche Diagnostics, Italy); Dulbecco's Modi®ed Eagle's medium (DMEM), foetal bovine serum (FBS) heat inactivated, L-glutamine (200 mM), penicillin/streptomycin (10,000 IU ml 71 ± 10,000 UG ml 71 ), Ca 2+ -Mg 2+ -free phosphate buered solution (PBS) (Gibco, Italy); Fura-2-AMester (Societa' Italiana Chimici, Italy). SLIGKV-NH 2 was synthesized at the Laboratory of Pharmaceutical Sciences of the University of Ferrara. The stock concentrations of capsaicin (10 mM), capsazepine (10 mM) and resiniferatoxin (10 mM) were prepared in 100% ethanol. Fura-2-AM-ester and ionomycin were dissolved in 100% DMSO. All other drugs were dissolved in distilled water. The appropriate dilutions were then made in Krebs buer solution.
Statistical analysis
The arithmetic mean and standard error of the mean were calculated throughout. Contractile responses are expressed as a percentage (%) of the response to CCh (1 mM). The concentration/dose of an agonist or antagonist that produced 50% of the maximal eect (EC 50 , IC 50 and ED 50 ) were obtained with an iterative curve ®tting package (GraphPad Prism Software, San Diego, CA, U.S.A.; Origin Software, Microcal Software, Northampton, MA, U.S.A.). Values for pK B , as a measure of the antagonist anity were calculated according to Kenakin (1993) . The pK B value was calculated for each tissue, with the ®nal value given as mean+s.e.mean. Statistical analysis was performed by means of the Student's t-test or analysis of variance (ANOVA) and the Dunnett's test when required. If P50.05 the results were considered signi®cant.
Results
Ca 2+ fluorescence measurements in cultured rat trigeminal ganglia and hTRPV1 HEK293 cells Capsaicin (0.1 mM) caused an increase in [Ca 2+ ] i in the vast majority (495%) of rat trigeminal neuronal cells (64+9% of ionomycin, n=85), that therefore were identi®ed as TRPV1 expressing neurons. The threshold concentration of I-RTX that produced an inhibitory eect was 0.1 nM and complete inhibition of the response to capsaicin was obtained with 10 nM I-RTX. IC 50 of I-RTX to inhibit capsaicin-evoked [Ca 2+ ] i mobilization was 0.87 nM (Figures 1 and 2 Practically all the hTRPV1 HEK293 cells responded to 0.1 mM capsaicin evoking a remarkable increase in [Ca 2+ ] i (54+3% of ionomycin, n=57). The threshold concentration of I-RTX to show an inhibitory eect was 0.03 nM and complete inhibition of the response to capsaicin was obtained with 3 nM I-RTX. IC 50 of I-RTX to inhibit capsaicin-evoked [Ca 2+ ] i mobilization was 0.071 nM ( Figure 1 and Table 1 ). For capsazepine (IC 50 was 912 nM) the threshold and blocking concentrations were 1 mM and 10 mM, respectively ( Table 1) . Mobilization of [Ca 2+ ] i evoked by the proteinase activated receptor-2 (PAR2) agonist, SLIGKV-NH 2 (10 mM) (87+6% of ionomycin, n=98) was not aected by I-RTX (1 mM) (97+12% of ionomycin, n=60). I-RTX (1 mM), in both rat trigeminal neurons and hTRPV1 HEK293 cells did not cause any visible increase in [Ca 2+ ] i .
CGRP-LI and SP-LI release from rat spinal cord
Next we examined the eect of TRPV1 antagonists on capsaicin-induced release of CGRP-LI and SP-LI from slices of rat spinal cord. Capsaicin (0.1 mM) increased CGRP-LI and SP-LI out¯ow (488+90 fmol g 71 20 min, n=5; and 31.5+3.5 fmol g 71 20 min, n=5, respectively). Exposure of spinal cord slices to either I-RTX (1 nM) or capsazepine British Journal of Pharmacology vol 138 (5) I-RTX abates TRPV1 mediated responses M. Rigoni et al (10 mM) did not produce any signi®cant increase in CGRP-LI or SP-LI (data not shown) out¯ow. Pre-treatment with I-RTX (0.01 ± 1 nM) and capsazepine (1 ± 10 mM, Figure 3 ) reduced the capsaicin-induced increase in CGRP-LI out¯ow in a concentration-dependent manner, with IC 50 that were 0.269 nM and 3802 nM, respectively (Table 1) . I-RTX (1 mM) did not alter the release induced by a high KCl (80 mM) concentration (Figure 3 ).
Contractile responses in isolated guinea-pig bronchus and urinary bladder, and rat urinary bladder
Capsaicin evoked a robust concentration-related contraction of guinea-pig isolated bronchi and urinary bladder, and rat urinary bladder. Threshold concentration of capsaicin to cause a visible contractile eect was 1 nM in all tissues tested, and maximum response (% of CCh 1 mM, E max ) obtained with 1 mM of capsaicin was 107+9% (n=20) in guinea-pig bronchus, 58+12% (n=15) in guinea-pig urinary bladder and 39+14% (n=12) in rat urinary bladder. Exposure to I-RTX (1 mM) did neither aect the baseline tension in all the three tissues examined nor change the response to CCh 1 mM (data not shown). I-RTX (1 nM ± 1 mM) caused a concentration-dependent and surmountable antagonism of capsaicininduced contraction in all the tissues tested. Schild plot analysis of the results revealed pK B values in the guinea-pig bronchi and urinary bladder of 7.26+0.40 (n=12, Figure 4 ) and 10.68+0.24 (n=10, Figure 5 ) respectively, and in rat urinary bladder of 9.63+0.30 (n=12, Figure 6) (Table 1) . A similar study was performed with capsazepine (0.1 ± 10 mM) against capsaicin-induced contraction: pK B values in the guinea-pig bronchus and urinary bladder were 6.29+0.31 (n=8, Figure 4 ) and 6.56+0.20 (n=8, Figure 5 ) respectively, and in the rat urinary bladder was 6.22+0.40 (n=9, Figure  6 ) (Table 1) . I-RTX (0.1 nM ± 1 mM) did not aect the cumulative concentration response curve produced by SP in isolated guinea-pig bronchi (Figure 4 ) and urinary bladder ( Figure 5 ), and rat urinary bladder ( Figure 6 ). I-RTX had no eect on baseline tone at any of the concentrations tested (1 nM, 10 nM, 100 nM and 1 mM) and in any of the isolated tissues (data not shown). In contrast, RTX (0.1 ± 100 nM) caused a robust contractile response starting at 0.3 nM producing a maximum contraction similar to that of capsaicin (data not shown).
Plasma protein extravasation in mouse urinary bladder
Intravenous (i.v.) injection of capsaicin (1 mmol kg 71 ) induced a signi®cant increase in plasma extravasation in mouse urinary bladder (11.2+1.3 ng EB/g of tissue, n=6) as compared to the extravasation produced by the vehicle of capsaicin (4.1+0.7 ng EB/g of tissue, n=6, P50.01). Pretreatment with I-RTX (0.1 ± 0.5 mmol kg 71 , i.v.) caused a dose-related inhibition (ED 50 0.41+0.08 mmol kg 71 , Figure 7 and Table 1 ). Capsazepine (0.5 ± 10 mmol kg 71 , i.v.) pretreatment also inhibited capsaicin-induced plasma extravasation in the urinary bladder with an estimated ED 50 of 9.03+1.02 mmol kg 71 (Figure 7 and Table 1 ). At the maximum dose used, I-RTX (0.5 mmol kg 71 , i.v.) alone neither produced any measurable increase in PE (data not shown) nor aected SP induced plasma extravasation in the mouse urinary bladder (Figure 7) .
Writhing in mice
Intraperitoneal injections of acetic acid (0.9%, 5 ml kg 71 ) evoked a signi®cant increase in stereotypical writhing responses over 20 min in mice. These writhing episodes were signi®cantly reduced by pre-treatment with I-RTX (0.1 ± 1 mmol kg 71 , i.p.) in a dose-related manner (ED 50 : 0.42+0.05 mmol kg 71 , Figure  8 ). Capsazepine (1 ± 10 mmol kg 71 , i.p.) also inhibited the acetic acid induced writhing responses in mice with an ED 50 of 7.90+1.13 mmol kg 71 (Figure 8 ). I-RTX (1 mmol kg 71 , i.p.) caused in a few instances (two out of six mice tested) a few writhing responses (510/20 min).
Discussion
In the present study, we have investigated the ability of I-RTX to inhibit`typical' neurogenic in¯ammatory and nociceptive responses produced by activation of TRPV1 in experimental preparations from dierent mammalian species. The main ®nding of this study is that I-RTX is a highly potent TRPV1 antagonist in all the paradigms and species examined, with the exception of the guinea-pig bronchus. First, we examined the ability of I-RTX to reduce the capsaicin-induced increase in [Ca 2+ ] i in cultured trigeminal neurons. In this preparation IC 50 value of I-RTX was in the subnanomolar range, thus showing that I-RTX was about three log units more potent than capsazepine. These data are in complete agreement with the study reported by Wahl et al. (2001) where they estimated that the K i of I-RTX for displacement of [ 125 I]-RTX binding from membranes of native (rat spinal cord) or recombinant (rat TRPV1 HEK293 cells) TRPV1 was approximately 1000 fold lower than that of capsazepine. In the present study I-RTX showed selectivity because at the highest concentration used it did not aect the increase in [Ca 2+ ] i produced by a high K + medium. Because KCl-induced [Ca 2+ ] i mobilization in sensory neurons is mediated by the in¯ux of extracellular Ca 2+ mainly through N and L type voltage sensitive Ca 2+ channels, these ®ndings indicate that I-RTX does not inhibit these type of channels. Furthermore, I-RTX showed a very high anity for the human TRPV1 expressed in HEK293 cells, where I-RTX inhibited the capsaicin-induced increase in [Ca 2+ ] i with an IC 50 of 0.071 nM con®rming a similar previous observation (McDonnell et al., 2002) . The inhibitory response of I-RTX was more than four log units lower than that of capsazepine and 10 fold lower than that observed for I-RTX at the rat TRPV1 which is consistent with recent ®nding that antagonism at TRPV1, in this case by capsazepine, is greater in cells expressing human TRPV1 as compared to the rat (McIntyre et al., 2001; Wahl et al., 2001) . HEK293 cells express constitutively the proteinase activated receptor-2 (PAR2) (Hollenberg et al., 1997) . The observation that I-RTX did not aect PAR2 agonist-induced increases in [Ca 2+ ] i indicates a degree of selectivity for the human TRPV1.
Increases in [Ca 2+ ] i produced by TRPV1 activation result in a series of intracellular events that lead to secretion of neuropeptides from peripheral and central endings of primary Figure 5 The eect of iodo-resiniferatoxin (I-RTX), capsazepine (CPZ) or their respective vehicles (empty circles) on the contraction produced by increasing concentrations of capsaicin (A, B) or substance P (C) (given in a cumulative manner) in isolated strips of guinea-pig urinary bladder. Each entry is the mean+s.e.mean of at least six experiments.
Figure 6
The eect of iodo-resiniferatoxin (I-RTX), capsazepine (CPZ) or their respective vehicles (empty circles) on the contraction produced by increasing concentrations of capsaicin (A, B) or substance P (C) (given in a cumulative manner) in isolated strips of rat urinary bladder. Each entry is the mean+s.e.mean of at least six experiments.
British Journal of Pharmacology vol 138 (5) I-RTX abates TRPV1 mediated responses M. Rigoni et al sensory neurons. SP and CGRP release from central terminals of primary aerents is considered to be a major function of nociceptors because it has been associated with pain transmission (Otsuka & Yanagisawa, 1990) . In this important assay I-RTX also proved to be a high anity antagonist of the rat TRPV1, being more than 1000 fold more potent than capsazepine. Again, the observation that 1 mM I-RTX did not aect the ability of high K + ion concentrations to release CGRP/SP indicates selectivity for TRPV1 over voltage-gated mechanisms.
Release of neuropeptides from peripheral terminals of primary sensory neurons that ensues from TRPV1 activation causes a series of responses collectively referred to as neurogenic in¯ammation' (Geppetti & Holzer, 1996) . In the airways and urinary bladder neurogenic in¯ammatory responses include contraction of the bronchial and urinary smooth muscle and extravasation of plasma proteins in postcapillary venules. I-RTX was extremely potent in inhibiting capsaicin-induced contractions of the guinea-pig and rat urinary bladder. As in other assays, the pK B of I-RTX was in both these cases more than three log units higher than that of capsazepine. At variance with all these observations, I-RTX potency to reduce capsaicin-induced contractions of guinea-pig bronchi was much lower (*100x) than that found in all the other preparations studied, and only slightly higher than that of capsazepine. This ®nding is consistent with previous reports that showed a low anity constant of RTX (either iodinated or not) in binding assays using guinea-pig bronchial tissues (Szallasi et al., 1993) . The observation that in the guinea-pig urinary bladder I-RTX shows a potency similar to that observed at the rat and human TRPV1, excludes that I-RTX has a low anity for the guinea-pig TRPV1, but rather suggests that some hitherto unknown mechanism(s), speci®c for the guinea-pig bronchus is responsible for the low capability of RTX (Szallasi et al., 1993) and I-RTX to bind and (I-RTX) inhibit the TRPV1 in this tissue.
One possible explanation for the remarkable potency of I-RTX to inhibit the TRPV1 in dierent mammal species is that this molecule retains some agonistic activity from the parent drug, RTX, that causes desensitization of TRPV1 and of downstream mechanisms resulting from TRPV1 activation (Szallasi et al., 1993) . However, the absolute absence of any visible agonist eect of low and even high I-RTX concentrations, in all the preparations tested, suggests that I-RTX does not act via ®rst activating and then desensitizing the TRPV1/ sensory nerve terminal, but most likely by its ability to antagonize the channel.
The low potency and poor selectivity for TRPV1 of ruthenium red and capsazepine has limited their use, particularly in in vivo studies. The present investigation, using a classical TRPV1 mediated in vivo response in the form of the capsaicin-induced plasma extravasation in the urinary bladder, shows that I-RTX is much more potent than capsazepine. The lack of eect of high doses of I-RTX upon SP-induced plasma extravasation indicates that TRPV1 and I-RTX act upstream of the release of tachykinins which stimulates NK 1 receptors on endothelial cells of the postcapillary venule and it provides further support for the selectivity of I-RTX both in vivo as well as in vitro. An important point for the use of I-RTX for pathophysiological investigations is to demonstrate that this compound may block responses induced by endogenous stimulants of TRPV1. Acidic media have been proposed to be putative endogenous agonists of TRPV1 (Bevan & Geppetti, 1994) and the cloning of the rat TRPV1 has con®rmed that protons stimulate this receptor (Tominaga et al., 1998) . A recent study, showing that capsazepine inhibits the acetic acid induced writhing behaviour in mice, suggested that this complex nociceptive response involves an aerent arm in which the TRPV1 has a role (Ikeda et al., 2001) . We found that I-RTX was about 20 fold more potent than capsazepine in reducing the acetic acid-induced writhing, which has two implications: ®rstly, it con®rms the data obtained using capsazepine using an additional antagonist, and secondly, that I-RTX may be used to test the ability of putative endogenous agonists to stimulate nociceptive responses activated by the TRPV1.
In conclusion the present investigation con®rms the early observation (Wahl et al., 2001 ) that I-RTX is a potent antagonist at the rat TRPV1. The study, for the ®rst time shows that I-RTX exhibits high anity for the TRPV1 in additional mammal species including the guinea-pig and human TRPV1. The fact that I-RTX at subnanomolar concentrations and with high selectivity blocks TRPV1mediated responses indicates that this molecule may be an invaluable tool for the restless search of the physiological role(s) and of the putative endogenous pain-producing agonist of TRPV1.
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